Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2026-01-05 @ 3:08 AM
Study NCT ID:
NCT05562466
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2022-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-23
First Submit QC Date:
None
Study First Post Date:
2022-09-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-24
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED